ProShares Ultra Bitcoin ETF vs Inovio Pharmaceuticals Inc — how do they compare? ProShares Ultra Bitcoin ETF trades at $9.35, while Inovio Pharmaceuticals Inc trades at $0.77 (market cap $78.55M). Which is the better fit depends on your goals.
| BITU | INO | |
|---|---|---|
Sector | Leveraged / Inverse | Health |
52-Week High | $64.41 | $2.87 |
52-Week Low | $8.12 | $0.66 |
Market Cap | — | $78.55M |
Enterprise Value | — | $49.56M |
Trailing returns across standard periods
BITU is a leveraged ETF that seeks to provide two times (2x) the daily performance of Bitcoin. It is designed for sophisticated investors looking for magnified exposure to Bitcoin’s daily price movements.
Read more on BITU →Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →